MedTrace Logo

Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells

NCT04446884 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-06-25

No results posted yet for this study

Summary

Treatment of women with stress urinary incontinence using injection of autologous adipose-derived mesenchymal stem cells mixed with collagen gel

Conditions

  • Stress Urinary Incontinence

Interventions

BIOLOGICAL

Autologous adipose-derived mesenchymal stem cells

Autologous adipose-derived mesenchymal stem cells mixed with collagen solution

OTHER

Standard treatment according to the Clinical protocols

Standard treatment according to the Clinical protocols

Sponsors & Collaborators

  • Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

    lead OTHER_GOV

Principal Investigators

  • Igor D Volotovski, Prof · Head of the Lab of Institute of Biophysics and Cell Engineering

  • Alexander Nechiporenko, Dr · Associate Professor of Department of Surgical Diseases

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Belarus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04446884 on ClinicalTrials.gov